ClinicalTrials.gg
Not yet recruitingNCT06270069Updated Feb 21, 2024

Responsiveness and Minimal Important Change of Two Measures of Pain Intensity in People With Low Back Pain

An observational study in Low Back Pain, sponsored by International Institute of Behavioral Medicines. Not yet recruiting. Open to participants aged 18 Years to 90 Years. Per ClinicalTrials.gov, last updated 2024-02-21.

Sponsored by International Institute of Behavioral Medicines · Observational

How we know

From the registry’s dates

  • Primary completion was expected by Feb 2025, 1 year 8 months ago, but the record still lists the study as not yet recruiting.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
150
Ages
18 Years to 90 Years
Sex
All
01

Study summary

This is an observational study aimed at evaluating the responsiveness and minimal important change of two measures of pain intensity in people with low back pain. It consists of a battery of self-administered questionnaires which will be given to individuals with low back pain to complete before and after a rehabilitation treatment. Relationships among the different outcome measures will be also evaluated.

Read the detailed description

This is an observational study aimed at evaluating the responsiveness and minimal important change of two different graphical ways to assess pain intensity in people with low back pain.

Literature found out that low back pain intensity is commonly assessed by a numerical rating scale ranging from no pain to the worst imaginable pain, once presented to responders horizontally. A different way to assess pain intensity could be to answer a similar numerical rating scale if set vertically.

In Literature there are not studies which head-to-head evaluate the responsiveness and minimal important change of these two ways of assessing pain intensity due to low back pain.

Participants will also have to complete self-reported outcome measures of disability, catastrophizing, fear of movement and self-efficacy, and correlations among these tools and the above two different ways to evaluate pain intensity will be evaluated. Descriptive statistics will be presented by taking into account the socio-demographic characteristics of the sample under investigation.

02

Conditions studied

  • Low Back Pain

Browse trials for

03

In context

Low Back Pain

2,930 studies on the registry are indexed under Low Back Pain; 581 are open to participants now.

This study's planned enrollment of 150 is above the median of 100 across 484 observational studies indexed under Low Back Pain.

Browse Low Back Pain studies →

Lead sponsor

International Institute of Behavioral Medicines is the lead sponsor of 6 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 90 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Non-specific low back pain is defined as low back pain not attributable to a recognizable, known specific pathology (eg, infection, tumour, osteoporosis, lumbar spine fracture, structural deformity, inflammatory disorder,radicular syndrome, or cauda equina syndrome).

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Non specific low back pain
  • Adult age
  • Ability to understand the Italian language

Exclusion criteria

Exclusion Criteria:

  • Refuse to adhere to the study
  • Definite causes of low back pain
  • Central or peripheral neurological signs
  • Systemic illness or psychiatric deficits
  • Recent myocardial infarction, cerebrovascular events, or chronic lung or renal diseases
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
150 participants (estimated)
Patient registry
No

Interventions

  • OtherExcercise-based therapy

    An individual 60-min motor training sessions twice a week for eight-week outpatient program, that included exercises aimed at improving postural control, strengthening and stabilizing the back muscles, and stretching

06

What researchers measure

Primary outcomes

  1. NRS

    Numerical Rating Scale; score 0-10 with higher estimates indicating higher levels of pain intensity (horizontal line)

    Time frame: Immediately before the rehab treatment starts and immediately after the intervention

  2. Gauge of pain

    Numerical Rating Scale; score -5/+5 with lower estimates indicating higher levels of pain intensity (vertical line)

    Time frame: Immediately before the rehab treatment starts and immediately after the intervention

Secondary outcomes

  1. ODI

    Oswestry Disability Index; score 0-50 with higher scores representing greater restriction to activities.

    Time frame: Immediately before the rehab treatment starts and immediately after the intervention

  2. PCS

    Pain Catastrophizing Scale; score 0-52 with higher estimates showing higher catastrophizing

    Time frame: Immediately before the rehab treatment starts and immediately after the intervention

  3. TSK

    Tampa Scale of Kinesiophobia; score 13-52 with higher estimates showing higher fear of movement

    Time frame: Immediately before the rehab treatment starts and immediately after the intervention

  4. PSEQ

    Pain Self Efficacy Questionnaire; score 0-60 with higher estimates showing higher self-effficacy

    Time frame: Immediately before the rehab treatment starts and immediately after the intervention

  5. GPE

    Global Perceived Effect (how much did the treatment received help your pain?); score -3 (it worsen a lot the things)/+3 (it helped a lot)

    Time frame: Immediately after the intervention

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Mar 2024; primary completion for Feb 2025, 11 months later.

Of 177 non-industry observational studies under Low Back Pain, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 48. This study's planned 11 months is below that.

Counting every sponsor, half of 187 studies reached it within 24 months; a quarter within 10 and three quarters within 48.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 5, 2024
First posted
Feb 21, 2024
StartEst.
Mar 1, 2024
Primary completionEst.
Feb 28, 2025
CompletionEst.
Feb 28, 2025
Last update
Feb 21, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 21, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06270069
Lead sponsor
International Institute of Behavioral Medicines
Responsible party
Sponsor
First posted
Feb 21, 2024
Start date
Mar 1, 2024 (estimated)
Primary completion
Feb 28, 2025 (estimated)
Completion
Feb 28, 2025 (estimated)
Last update
Feb 21, 2024

Study contacts

Barbara Rocca, MSC
Contact
info.ellis.bm@gmail.com
3333653393

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Feb 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion